lobbying_activities: 3805914

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3805914	1f4c4726-d6a6-425c-9bd1-3d97d5054fc3	Q1	STUDENTS FOR SENSIBLE DRUG POLICY	401105102	STUDENTS FOR SENSIBLE DRUG POLICY	2026	first_quarter	CIV	STATES 2.0 Act (HR 2934): Issues related state cannabis laws and provisions to enable interstate commerce. PREPARE Act (HR 2935): Issues related to the establishment of a federal commission to design a pathway for full federal cannabis regulation. Evidence-Based Drug Policy Act (HR 3082): Issues related to the authorization of federal agencies to study cannabis legalization and stops requiring the Drug Czar to oppose reform efforts. MORE Act (HR 5068): Issues related to the removal of cannabis from the Controlled Substances Act, expunging certain past convictions, and reinvesting in communities disproportionately harmed by prohibition. The End Needless Distribution of 7-OH Act (H.R. 8000): Issues related to restricting the distribution of synthetic 7-OH products by treating them as a federally controlled substance with no accepted medical use.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2026-04-12T15:57:11-04:00